Skip to content

Study · Observational study · n = 380 · 2014

2 results

Predictors of response to liraglutide in Japanese type 2 diabetes.

Toyoda M, Yokoyama H, Abe K, Nakamura S, Suzuki D

Diabetes research and clinical practice7 Oct 2014Cited by 14 (Europe PMC)

PMID25458335 (opens in a new tab)DOI10.1016/j.diabres.2014.09.052 (opens in a new tab)PepBankPUB-25458335
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanObservational studyOther

    In Japanese adults with type 2 diabetes treated with liraglutide, high BMI, long duration of diabetes and prior insulin therapy were associated with discontinuation of liraglutide.

    In plain wordsIn Japanese adults with type 2 diabetes, high BMI, long diabetes duration and earlier insulin use were linked to stopping liraglutide.

    Peptide
    Liraglutide
    Outcome
    Not applicableFactors associated with discontinuation of liraglutide
    Study

    n = 380

    Outcome group
    Treatment adherence and retention · Metabolic and weight
    Studied dose
    up to 0.9 mg/dayAs given in this study (human).

    Source sentences

    Summary
    Factors associated with discontinuation of liraglutide included high BMI, long duration of diabetes, and prior insulin therapy.
    1 context sentence
    Summary · context
    This observational retrospective study included 380 patients with T2DM who were treated with liraglutide alone or in combination with sulfonylureas at Diabetes Centers located in four geographically different areas of Japan.
  2. 02HumanObservational studyOther

    In Japanese adults with type 2 diabetes who had not used insulin before, previous use of few oral glucose-lowering agents and high baseline HbA1c level predicted response to liraglutide.

    In plain wordsIn Japanese adults with type 2 diabetes without prior insulin, few earlier tablets and a high starting HbA1c were linked to a better liraglutide response.

    Peptide
    Liraglutide
    Outcome
    Not applicablePredictors of response to liraglutide
    Study

    n: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    up to 0.9 mg/dayAs given in this study (human).

    Source sentences

    Summary
    Predictors of response to liraglutide therapy in patients who did not use insulin previously included previous use of few oral glucose-lowering agents and high baseline HbA1c level.
    1 context sentence
    Summary · context
    This observational retrospective study included 380 patients with T2DM who were treated with liraglutide alone or in combination with sulfonylureas at Diabetes Centers located in four geographically different areas of Japan.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:10 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.